Frontier IP (GB:FIPP) has released an update.
Frontier IP Group plc has announced a 4.26% stake in DiaGen Ai Inc, a company specializing in AI-driven protein and peptide design for medical applications, as part of a collaboration to enhance animal vaccine development. The partnership leverages DiaGen’s artificial intelligence capabilities and The Vaccine Group’s experience to create vaccines for diseases with high mutation rates. This strategic alliance aims to address significant gaps in the veterinary vaccine market by developing broadly protective vaccine candidates.
For further insights into GB:FIPP stock, check out TipRanks’ Stock Analysis page.
